Hepatic Impairment (HI)
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| Nemtabrutinib | Merck & Co., Inc. (MRK) |
Frequently asked questions
How many drugs are in development for Hepatic Impairment (HI)?
BioSniper tracks 1 drug in development for Hepatic Impairment (HI) across 1 company.
How many clinical trials target Hepatic Impairment (HI)?
There are 3 clinical trials targeting Hepatic Impairment (HI) tracked by BioSniper.
Deep-dive into Hepatic Impairment (HI)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis